Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
2.710
+0.040 (1.50%)
At close: Sep 26, 2025, 4:00 PM EDT
2.700
-0.010 (-0.37%)
After-hours: Sep 26, 2025, 7:52 PM EDT
Neuronetics Employees
Neuronetics had 716 employees as of December 31, 2024. The number of employees increased by 513 or 252.71% compared to the previous year.
Employees
716
Change (1Y)
513
Growth (1Y)
252.71%
Revenue / Employee
$155,176
Profits / Employee
-$68,154
Market Cap
179.20M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
STIM News
- 10 days ago - New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD) - GlobeNewsWire
- 7 weeks ago - Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Neuronetics, Inc. (STIM) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference - GlobeNewsWire
- 2 months ago - NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents - GlobeNewsWire
- 2 months ago - Neuronetics Appoints New Chief Financial Officer - GlobeNewsWire
- 3 months ago - Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook's Personalized Care Trial Program - GlobeNewsWire
- 4 months ago - Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes - GlobeNewsWire